The Regulatory Mismatch: Why Private Equity’s Insurance Playbook Is Raising Alarms

The recent unfolding debacle surrounding Mark Walter’s Delaware Life has ignited a fierce debate regarding the adequacy of U.S. insurance oversight. In a candid critique of the current regulatory environment, Apollo Global Management CEO Marc Rowan recently pointed to the firm’s affiliate transactions—specifically those involving high-profile sports teams—as a red flag that should have been immediately apparent to any diligent regulator.

“If one was not aware of affiliate transactions relating to three high-profile sports teams that we can all name, what are you doing as a regulator?” Rowan asked. His comments were not merely a jab at a competitor; they served as a broader warning about a growing “race to the bottom” in state-level insurance oversight. Rowan cautioned that this environment is effectively creating “onshore Caymans,” where regulatory scrutiny is bypassed through complex corporate structures.

For many industry observers, the irony of these comments is palpable. As the head of the firm that pioneered the private equity-owned annuity model through Athene, Rowan is at the center of the very industry shift he now critiques. However, the situation at Delaware Life is far from an isolated anomaly. Instead, it serves as the latest chapter in a 45-year historical narrative of increasingly complex Wall Street financial products being overseen by a fragmented, often ill-equipped system of Main Street regulators.

1979: A Wall Street Product Lands on a Main Street Desk

To understand the current tension, one must look back to 1979. A small California-based carrier, later renamed E.F. Hutton Life, introduced a product called Universal Life (UL). It was a revolutionary financial instrument that unbundled the traditional whole life insurance policy, allowing it to compete head-on with money market funds during a period characterized by double-digit interest rates. By 1983, virtually every major insurer in the United States had scrambled to offer its own version of the product.

This shift presented a fundamental challenge for regulators. Universal Life was a rate-sensitive, highly complex product engineered by Wall Street firms, yet it was being governed by state insurance commissioners whose frameworks were designed for the static, guaranteed nature of traditional whole life insurance. This decision—to allow sophisticated, market-dependent products to be regulated by a system built for a bygone era—established a dangerous precedent. As the years progressed, the sophistication of financial products and corporate balance sheets grew exponentially, yet the regulatory “referee” remained largely unchanged.

The Bills Come Due

The consequences of this regulatory lag became painfully clear as interest rates began a sustained decline through the late 1980s and 1990s. Universal Life policies, which had been sold to consumers based on aggressive 11% and 12% yield illustrations, failed to meet those projections. The phenomenon of “vanishing premiums”—where the policyholder’s dividends were expected to cover future costs—failed to materialize, leading to billions of dollars in sales-practice litigation that crippled the industry.

The parallels to today’s indexed universal life products are striking to veteran observers. The systemic risk peaked in 1991, when Executive Life collapsed under the weight of roughly $9 billion in junk bonds, marking the largest insurance failure in U.S. history at the time. That same year, California regulators seized First Capital Life, the successor to the original Hutton Life. These failures were the first clear warning that the gap between market complexity and regulatory capability was widening.

A New Master, and the Search for Capital Relief

Following the industry turbulence of the 1990s, the sector underwent a wave of demutualization. Many of America’s oldest and most respected life insurers, such as Equitable, found themselves near the brink of insolvency, burdened by guaranteed interest contracts written during the high-rate era of the 1980s. To survive, these firms turned to global capital, with Equitable famously finding a “white knight” in the French giant AXA. While this move provided necessary liquidity, it also introduced a new master to the industry: shareholders who demanded consistent quarterly earnings from firms built on promises lasting 40 years or more.

By 2008, the pressure for performance intensified. When the financial crisis exposed the mispricing of variable annuity guarantees, carriers increasingly turned to financial engineering. They began shifting reserves into captive reinsurers—often located in “friendly” states or offshore jurisdictions—to manage capital requirements. By 2013, New York regulators had identified $48 billion in “shadow insurance” at New York-based insurers alone. The playbook for moving liabilities out of the reach of traditional regulators was firmly established.

Private Equity Reads the Rulebook

Private equity firms simply took this established strategy and scaled it to unprecedented levels. In 2009, Apollo helped found Athene, operating on an elegant, if controversial, insight: own the insurer, invest its long-dated annuity capital in credit originated by the firm, and earn fees on both sides of the transaction while capturing the spread. The success of this model triggered a gold rush, with firms like KKR acquiring Global Atlantic and Blackstone moving into the sector with the acquisition of Allstate Life.

According to data from ALIRT, privately owned insurers expanded their footprint from just 2.5% of U.S. life industry invested assets in 2011 to nearly 20% by the end of 2025, representing roughly $1.2 trillion in assets. While proponents argue that private equity brought much-needed capital, investment expertise, and competitive rates to the consumer market, these benefits often rest on regulatory arbitrage. This includes capital rules that favor private assets, reliance on issuer-paid rating agencies, and the use of affiliated reinsurers in Bermuda or the Cayman Islands that operate largely outside the view of U.S. authorities. When one entity controls the insurer, the asset manager, and the reinsurer, every transaction effectively becomes a related-party transaction, creating significant conflicts of interest.

The results are beginning to surface. At A-CAP, owned by 777 Partners, reports surfaced that policyholder funds had flowed into the owner’s own ventures. PHL Variable, owned by Golden Gate Capital, is currently heading toward liquidation with a $2 billion deficit, shattering the industry’s long-standing assumption that policyholders will always be made whole. Even Delaware Life, which has maintained that its capital position remains strong and has not been charged with any wrongdoing, saw its reported related-party investments swell from $1.4 billion to over $17 billion—amounting to 39% of its total invested assets.

The Wrong Referee for the Game

The root of the issue is structural. Since the McCarran-Ferguson Act of 1945, insurance in the United States has been regulated on a state-by-state basis by officials whose primary mandate is consumer protection. However, these offices are often staffed by elected or appointed individuals who may lack the specialized financial background necessary to navigate modern portfolios, structured credit products like CLOs, or complex reinsurance treaties.

The commissioner for Delaware, who holds primary responsibility for Delaware Life, transitioned to the role after a two-decade career in law enforcement. While this is not a personal indictment, it highlights the systemic failure to require technical expertise for those overseeing multibillion-dollar financial institutions. As former Mississippi examiner Tom Gober has famously noted, many state insurance departments remain underfunded, understaffed, and under-sophisticated compared to the entities they oversee. Despite the NAIC adopting new related-party reporting codes in 2022, Delaware Life’s filings still managed to understate its affiliate exposure by more than tenfold, proving that rules alone are insufficient without the teeth to enforce them.

The path forward does not necessarily involve driving private capital out of the insurance sector, which would likely harm consumer access and pricing. Instead, the challenge is to align the “referee” with the complexity of the game. For advisors, the current environment necessitates extreme caution. Until comprehensive reforms are implemented, professionals must prioritize due diligence: understanding exactly who owns the carriers they recommend, assuming that a private equity parent may not necessarily bail out a failing subsidiary, and matching the duration of the policy to the trust placed in the institution.

Ultimately, the crisis at Delaware Life is merely the tip of the iceberg. Over the past four decades, from the failure of vanishing premiums to the shadow insurance era, the industry has seen a repeated cycle of sophisticated Wall Street products clashing with a Main Street regulatory apparatus. Without a fundamental shift toward providing regulators with the talent, tools, and authority to see beneath the waterline, the industry remains vulnerable to the next inevitable shock.